Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution.

By D. Dohan, J. Choukroun, A. Diss, Steve L Dohan, A. Dohan, J. Mouhyi, B. Gogly. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2006

1,801 citations recorded by the source corpus.

Subfields: Dermatology, Hematology, Urology

View Paper: https://www.semanticscholar.org/paper/9e3a6d13c56be86317a0224cac0f0d828d4fe294

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

1. D. M. Dohan Ehrenfest
2. P. Doglioli
3. G. Sammartino
4. G. M. de Peppo

In Urology

1. D. M. Dohan Ehrenfest
2. P. Doglioli
3. G. Sammartino
4. G. M. de Peppo

Citations in the corpus

• Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. (2014, methodology): “The PRF scaffolds were prepared according to a previously published protocol.(11,26) Four healthy (ie, with no history of anticoagulant usage) volunteers in an age range between 18 to 60 years participated in this study.”
• Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies (2009, methodology): “Previous studies suspected this phenomenon with indirect proofs (Dohan et al. 2006a,b): after quantification of many different residual cytokines (growth factors and interleukins) within the supernatant and the clot exudate soon after PRF preparation, the cytokine amounts were found very low in…”